In the past one year, the Nifty Pharma Index has shed 12.4% as against the 1% gains in the benchmark Nifty 50. Mutual Funds that bet on pharma stocks have fallen 14.2% on an average in the past one year. So far in 2022, they have declined 12.4% on an average, according to Value Research.
Rate cut expected, RBI’s views in focus with economy near a sizzle
Economists anticipate the Reserve Bank of India will reduce interest rates this week. This decision comes amid decreasing inflation. Experts await the central bank’s insights